Study of an Interposition Supraciliary Implant in Patients With Open Angle Glaucoma

NCT05159817 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2023-02-13

No results posted yet for this study

Summary

The purpose of this study is to prolong observational follow-up up to 36 months of patients already implanted with a novel interposition supraciliary implant.

Conditions

  • Glaucoma, Open-Angle

Sponsors & Collaborators

  • Ciliatech

    lead INDUSTRY

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-15
Primary Completion
2024-02-28
Completion
2024-12-31

Countries

  • Armenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05159817 on ClinicalTrials.gov